01 1Piramal Pharma Limited
01 1Tafenoquine succinate
01 1U.S.A
NDC Package Code : 65085-0061
Start Marketing Date : 2018-07-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
69
PharmaCompass offers a list of Tafenoquine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tafenoquine manufacturer or Tafenoquine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tafenoquine manufacturer or Tafenoquine supplier.
PharmaCompass also assists you with knowing the Tafenoquine API Price utilized in the formulation of products. Tafenoquine API Price is not always fixed or binding as the Tafenoquine Price is obtained through a variety of data sources. The Tafenoquine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Arakoda manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Arakoda, including repackagers and relabelers. The FDA regulates Arakoda manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Arakoda API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Arakoda supplier is an individual or a company that provides Arakoda active pharmaceutical ingredient (API) or Arakoda finished formulations upon request. The Arakoda suppliers may include Arakoda API manufacturers, exporters, distributors and traders.
click here to find a list of Arakoda suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Arakoda as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Arakoda API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Arakoda as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Arakoda and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Arakoda NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Arakoda suppliers with NDC on PharmaCompass.
We have 1 companies offering Arakoda
Get in contact with the supplier of your choice:
